NAS:AMRS (USA) Also trade in: Germany

Amyris Inc

$ 4.09 0 (0%)
Volume: 1,333,839 Avg Vol (1m): 3,093,550
Market Cap $: 382.43 Mil Enterprise Value $: 520.62 Mil
P/E (TTM): 0.00 P/B: 0.00
Earnings Power Value -26.46
Net Current Asset Value -3.13
Tangible Book -2.35
Projected FCF -20.17
Median P/S Value 8.63
Graham Number 0
Peter Lynch Value 0
DCF (FCF Based) 0
DCF (Earnings Based) 0
YTD (-%)

Financial Strength : 2/10

GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
Current vs industry vs history
Cash-to-Debt 0.22
Cash-To-Debt ranked lower than
90.11% of 1122 companies
in the Specialty Chemicals industry.
Industry Max: 33470, Med: 0.72, Min: 0.01
AMRS: 0.22
Ranked among companies with meaningful Cash-To-Debt only.
Cash-To-Debt range over the past 10 years
Min: 0.01, Med: 0.35, Max: 22.66
Current: 0.22
0.01
22.66
Equity-to-Asset -1.04
Equity-to-Asset ranked lower than
99.54% of 1092 companies
in the Specialty Chemicals industry.
Industry Max: 0.98, Med: 0.57, Min: -3.61
AMRS: -1.04
Ranked among companies with meaningful Equity-to-Asset only.
Equity-to-Asset range over the past 10 years
Min: -2.47, Med: -0.69, Max: 0.87
Current: -1.04
-2.47
0.87
Debt-to-Equity -0.83
Debt-to-Equity ranked lower than
100.00% of 931 companies
in the Specialty Chemicals industry.
Industry Max: 119, Med: 0.39, Min: 0.01
AMRS: -0.83
Ranked among companies with meaningful Debt-to-Equity only.
Debt-to-Equity range over the past 10 years
Min: -1.87, Med: -0.66, Max: 61.63
Current: -0.83
-1.87
61.63
Debt-to-EBITDA -1.25
Debt-to-EBITDA ranked lower than
100.00% of 913 companies
in the Specialty Chemicals industry.
Industry Max: 405.11, Med: 2.12, Min: 0.01
AMRS: -1.25
Ranked among companies with meaningful Debt-to-EBITDA only.
Debt-to-EBITDA range over the past 10 years
Min: -6.22, Med: -0.38, Max: 4.71
Current: -1.25
-6.22
4.71
Piotroski F-Score 5
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -18.07
DISTRESS
GREY
SAFE
Beneish M-Score -0.94
Not Manipulator
Manipulator
WACC vs ROIC %
ROIC 0%
WACC 12.73%

Profitability & Growth : 3/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
Current vs industry vs history
Operating Margin % -141.88
Operating Margin ranked lower than
94.94% of 1107 companies
in the Specialty Chemicals industry.
Industry Max: 469.95, Med: 8.34, Min: -685674.44
AMRS: -141.88
Ranked among companies with meaningful Operating Margin only.
Operating Margin range over the past 10 years
Min: -318.69, Med: -171.77, Max: -27.55
Current: -141.88
-318.69
-27.55
Net Margin % -262.81
Net Margin ranked lower than
97.38% of 1106 companies
in the Specialty Chemicals industry.
Industry Max: 8294.93, Med: 5.82, Min: -760520.33
AMRS: -262.81
Ranked among companies with meaningful Net Margin only.
Net Margin range over the past 10 years
Min: -638.16, Med: -133.28, Max: 5.28
Current: -262.81
-638.16
5.28
ROA % -154.55
ROA ranked lower than
99.12% of 1134 companies
in the Specialty Chemicals industry.
Industry Max: 253.45, Med: 4.78, Min: -2284.37
AMRS: -154.55
Ranked among companies with meaningful ROA only.
ROA range over the past 10 years
Min: -154.55, Med: -55.57, Max: 1.1
Current: -154.55
-154.55
1.1
ROC (Joel Greenblatt) % -1054.31
ROC (Joel Greenblatt) ranked lower than
98.50% of 1130 companies
in the Specialty Chemicals industry.
Industry Max: 1816.36, Med: 14.65, Min: -69927.08
AMRS: -1054.31
Ranked among companies with meaningful ROC (Joel Greenblatt) only.
ROC (Joel Greenblatt) range over the past 10 years
Min: -1054.31, Med: -137.24, Max: 26.1
Current: -1054.31
-1054.31
26.1
3-Year Total Revenue Growth Rate 49.10
3-Year Revenue Growth Rate ranked lower than
80.04% of 1052 companies
in the Specialty Chemicals industry.
Industry Max: 343.1, Med: 1.7, Min: -100
AMRS: -5.8
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
3-Year Revenue Growth Rate range over the past 10 years
Min: -54.3, Med: -40.8, Max: 6
Current: -5.8
-54.3
6
3-Year EPS w/o NRI Growth Rate 40.20
3-Year EPS w/o NRI Growth Rate ranked higher than
81.75% of 904 companies
in the Specialty Chemicals industry.
Industry Max: 912.7, Med: 11.1, Min: -498.8
AMRS: 40.2
Ranked among companies with meaningful 3-Year EPS w/o NRI Growth Rate only.
3-Year EPS w/o NRI Growth Rate range over the past 10 years
Min: 0, Med: 35.6, Max: 48.1
Current: 40.2
0
48.1

» AMRS's 30-Y Financials

Financials (Next Earnings Date: 2019-08-06)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NAS:AMRS

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Chemicals » Specialty Chemicals    NAICS : 325199    SIC : 2899
Compare LSE:ZTF SZSE:002915 SZSE:300200 IST:POLHO TSE:5304 SZSE:300731 TSE:4109 SHSE:600599 SZSE:002886 SZSE:002319 SZSE:002360 NAS:HWKN SHSE:603798 SZSE:002917 SZSE:002809 NYSE:OMN SZSE:300063 ATH:PLAKR SZSE:300192 SZSE:300537
Traded in other countries 3A01.Germany
Address 5885 Hollis Street, Suite 100, Emeryville, CA, USA, 94608
Amyris Inc is an industrial biotechnology company. It is engaged in the engineering, manufacturing, and sales of products in a variety of consumer and industrial markets, including cosmetics, flavors and fragrances, solvents and cleaners, polymers, lubricants, healthcare products, and fuels. The business operations are spread across the world with the majority of the revenues generated in the United States.

Ratios

Current vs industry vs history
PS Ratio 1.46
PS Ratio ranked lower than
66.18% of 1085 companies
in the Specialty Chemicals industry.
Industry Max: 3971.43, Med: 1.27, Min: 0.01
AMRS: 1.46
Ranked among companies with meaningful PS Ratio only.
PS Ratio range over the past 10 years
Min: 0.52, Med: 3.1, Max: 9.62
Current: 1.46
0.52
9.62
EV-to-EBIT -3.00
EV-to-EBIT ranked lower than
100.00% of 986 companies
in the Specialty Chemicals industry.
Industry Max: 8127.7, Med: 14.73, Min: 0.1
AMRS: -3
Ranked among companies with meaningful EV-to-EBIT only.
EV-to-EBIT range over the past 10 years
Min: -275.9, Med: -3.4, Max: 17.5
Current: -3
-275.9
17.5
EV-to-EBITDA -3.08
EV-to-EBITDA ranked lower than
100.00% of 1002 companies
in the Specialty Chemicals industry.
Industry Max: 6596.67, Med: 11.5, Min: 0.1
AMRS: -3.08
Ranked among companies with meaningful EV-to-EBITDA only.
EV-to-EBITDA range over the past 10 years
Min: -27.2, Med: -3.6, Max: 35.2
Current: -3.08
-27.2
35.2
EV-to-Revenue 6.47
EV-to-Revenue ranked lower than
80.05% of 1098 companies
in the Specialty Chemicals industry.
Industry Max: 38643.75, Med: 1.45, Min: 0.01
AMRS: 6.47
Ranked among companies with meaningful EV-to-Revenue only.
EV-to-Revenue range over the past 10 years
Min: 0.3, Med: 5.8, Max: 15.2
Current: 6.47
0.3
15.2
Current Ratio 0.44
Current Ratio ranked lower than
94.27% of 1116 companies
in the Specialty Chemicals industry.
Industry Max: 6206.34, Med: 1.9, Min: 0.01
AMRS: 0.44
Ranked among companies with meaningful Current Ratio only.
Current Ratio range over the past 10 years
Min: 0.16, Med: 0.99, Max: 11.36
Current: 0.44
0.16
11.36
Quick Ratio 0.40
Quick Ratio ranked lower than
88.26% of 1116 companies
in the Specialty Chemicals industry.
Industry Max: 6206.34, Med: 1.37, Min: 0.01
AMRS: 0.4
Ranked among companies with meaningful Quick Ratio only.
Quick Ratio range over the past 10 years
Min: 0.09, Med: 0.93, Max: 11.22
Current: 0.4
0.09
11.22
Days Inventory 66.05
Days Inventory ranked higher than
65.86% of 1075 companies
in the Specialty Chemicals industry.
Industry Max: 755.99, Med: 64.18, Min: 0.02
AMRS: 66.05
Ranked among companies with meaningful Days Inventory only.
Days Inventory range over the past 10 years
Min: 11.23, Med: 42.83, Max: 139.58
Current: 66.05
11.23
139.58
Days Sales Outstanding 110.54
Days Sales Outstanding ranked higher than
57.12% of 1082 companies
in the Specialty Chemicals industry.
Industry Max: 840.31, Med: 68.33, Min: 0.01
AMRS: 110.54
Ranked among companies with meaningful Days Sales Outstanding only.
Days Sales Outstanding range over the past 10 years
Min: 7.75, Med: 33.25, Max: 110.54
Current: 110.54
7.75
110.54
Days Payable 294.26
Days Payable ranked higher than
93.59% of 1061 companies
in the Specialty Chemicals industry.
Industry Max: 850.06, Med: 56.72, Min: 1
AMRS: 294.26
Ranked among companies with meaningful Days Payable only.
Days Payable range over the past 10 years
Min: 10.32, Med: 67.41, Max: 294.26
Current: 294.26
10.32
294.26

Dividend & Buy Back

Current vs industry vs history
3-Year Share Buyback Rate -105.20
3-Year Share Buyback Rate ranked lower than
98.56% of 627 companies
in the Specialty Chemicals industry.
Industry Max: 100, Med: -3.8, Min: -364.2
AMRS: -105.2
Ranked among companies with meaningful 3-Year Share Buyback Rate only.
3-Year Share Buyback Rate range over the past 10 years
Min: -143.6, Med: -52.9, Max: -19.9
Current: -105.2
-143.6
-19.9

Valuation & Return

Current vs industry vs history
Price-to-Median-PS-Value 0.47
Price-to-Median-PS-Value ranked higher than
86.20% of 1029 companies
in the Specialty Chemicals industry.
Industry Max: 266.29, Med: 1.08, Min: 0.01
AMRS: 0.47
Ranked among companies with meaningful Price-to-Median-PS-Value only.
Price-to-Median-PS-Value range over the past 10 years
Min: 0.22, Med: 1.06, Max: 3.14
Current: 0.47
0.22
3.14
Earnings Yield (Joel Greenblatt) % -33.10
Earnings Yield (Greenblatt) ranked lower than
96.56% of 1133 companies
in the Specialty Chemicals industry.
Industry Max: 1000, Med: 5.92, Min: -400
AMRS: -33.1
Ranked among companies with meaningful Earnings Yield (Greenblatt) only.
Earnings Yield (Greenblatt) range over the past 10 years
Min: -500.7, Med: -28.5, Max: 7.6
Current: -33.1
-500.7
7.6

More Statistics

Revenue (TTM) (Mil) $ 80.42
EPS (TTM) $ -4.24
Beta 1.32
Volatility % 154.59
52-Week Range $ 1.87 - 9.29
Shares Outstanding (Mil) 93.5

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 5
Positive ROA N
Positive CFROA N
Higher ROA yoy Y
CFROA > ROA Y
Lower Leverage yoy Y
Higher Current Ratio yoy N
Less Shares Outstanding yoy N
Higher Gross Margin yoy Y
Higher Asset Turnover yoy Y